It was inferred that NF-κB p65 (RelA) and TNFα might be an early diagnostic marker for GBM patients since the expression trend of the NF-κB p65 (RelA) and TNFα proteins was essentially compatible with the transcript [48]. This evidence concerns the gene NFKB1 and glioblastoma.